Cited by CrossRef (44)
- Xiaosheng Li, Yue Chen, Anlong Sun, Ying Wang, Yao Liu, Haike Lei. Development and validation of prediction model for overall survival in patients with lymphoma: a prospective cohort study in China. BMC Med Inform Decis Mak 2023;23
- Ivan Dzis, Oleksandra Tomashevska, Yevhen Dzis, Zoryana Korytko. Prediction of survival in non-Hodgkin lymphoma based on markers of systemic inflammation, anemia, hypercoagulability, dyslipidemia, and Eastern Cooperative Oncology Group performance status. 2020;51:34
- Jihoon Kang, Shinkyo Yoon, Cheolwon Suh. Relevance of prognostic index with β2-microglobulin for patients with diffuse large B-cell lymphoma in the rituximab era. Blood Res 2017;52:276
- Ze Jin, Yi Miao, Jie Zhang, Jing Zhang, Chunling Wang, Xuzhang Lu, Yuqing Miao, Miao Sun, Yunping Zhang, Yun Zhuang, Haiwen Ni, Jingyan Xu, Wanchuan Zhuang, Min Zhao, Jianfeng Zhu, Min Xu, Guoqiang Lin, Haiying Hua, Xiaoyan Xie, Maozhong Xu, Tao Jia, Lijia Zhai, Weiying Gu, Qiurong Shan, Zhi Wang, Qiudan Shen, Xiaohui Zhang, Jianyong Li, Wenyu Shi. The clinical significance and prognostic value of serum beta-2 microglobulin in adult lymphoma-associated hemophagocytic lymphohistiocytosis: a multicenter analysis of 326 patients. Ann Hematol 2024
- Changhoon Yoo, Dok Hyun Yoon, Shin Kim, Jooryung Huh, Chan-Sik Park, Chan-Jeong Park, Sang-Wook Lee, Cheolwon Suh. Serum beta-2 microglobulin as a prognostic biomarker in patients with mantle cell lymphoma. Hematol Oncol 2016;34:22
- Da-Yong Huang, Yi-Fei Hu, Na Wei, Li Fu, Lin Wu, Jing Shen, Jing-Shi Wang, Zhao Wang. Innovative analysis of predictors for overall survival from systemic non-Hodgkin T cell lymphoma using quantile regression analysis. 2019;132:294
- Hyung‐Don Kim, Hyungwoo Cho, Hyehyun Jeong, Kyunghye Bang, Shin Kim, Kyoungmin Lee, Eun Hee Kang, Jung Sun Park, Chan‐Sik Park, Jooryung Huh, Jin‐Sook Ryu, Sang‐Wook Lee, Dok Hyun Yoon, Sung Yong Oh, Cheolwon Suh. A prognostic index for extranodal marginal‐zone lymphoma based on the mucosa‐associated lymphoid tissue International Prognostic Index and serum β2‐microglobulin levels. Br J Haematol 2021;193:307
- Susan Moradinasab, Atieh Pourbagheri-Sigaroodi, Seyed H. Ghaffari, Davood Bashash. Targeting macrophage-mediated tumor cell phagocytosis: An overview of phagocytosis checkpoints blockade, nanomedicine intervention, and engineered CAR-macrophage therapy. International Immunopharmacology 2022;103:108499
- Tamseela Mumtaz, Muhammad Amir Iqbal, Nabila Roohi, Muhammad Waheed Akhtar. Increased Turnover of Beta 2 Microglobulin in Circulation serves as Diagnostic and Prognostic Marker for Malignant Lymphoma; A Case Control Predictive Model for Lymphoma Diagnosis. PJHS 2023:160
- Theodoros P. Vassilakopoulos, Maria Arapaki, Panagiotis T. Diamantopoulos, Athanasios Liaskas, Fotios Panitsas, Marina P. Siakantaris, Maria Dimou, Styliani I. Kokoris, Sotirios Sachanas, Marina Belia, Chrysovalantou Chatzidimitriou, Elianna A. Konstantinou, John V. Asimakopoulos, Kyriaki Petevi, George Boutsikas, Alexandros Kanellopoulos, Alexia Piperidou, Maria-Ekaterini Lefaki, Angeliki Georgopoulou, Anastasia Kopsaftopoulou, Kalliopi Zerzi, Ioannis Drandakis, Maria N. Dimopoulou, Marie-Christine Kyrtsonis, Panayiotis Tsaftaridis, Eleni Plata, Eleni Variamis, Gerassimos Tsourouflis, Flora N. Kontopidou, Kostas Konstantopoulos, Gerassimos A. Pangalis, Panayiotis Panayiotidis, Maria K. Angelopoulou. Prognostic Impact of Serum β2-Microglobulin Levels in Hodgkin Lymphoma Treated with ABVD or Equivalent Regimens: A Comprehensive Analysis of 915 Patients. Cancers 2024;16:238
- Javier I. Muñoz-González, Iván Álvarez-Twose, María Jara-Acevedo, Ana Henriques, Esther Viñas, Carlos Prieto, Laura Sánchez-Muñoz, Carolina Caldas, Andrea Mayado, Almudena Matito, Noelia Dasilva-Freire, Alberto Orfao, Andrés C. García-Montero. Frequency and prognostic impact of KIT and other genetic variants in indolent systemic mastocytosis. 2019;134:456
- Mahsa Khanlari, Jennifer R. Chapman. Follicular lymphoma: updates for pathologists. J Pathol Transl Med 2022;56:1
- Denis Miyashiro, José Antonio Sanches. Mycosis fungoides and Sézary syndrome: clinical presentation, diagnosis, staging, and therapeutic management. Front. Oncol. 2023;13
- Kazuho Miyashita, Naoto Tomita, Masataka Taguri, Taisei Suzuki, Yasufumi Ishiyama, Yoshimi Ishii, Yuki Nakajima, Ayumi Numata, Yukako Hattori, Wataru Yamamoto, Takuya Miyazaki, Takayoshi Tachibana, Hirotaka Takasaki, Kenji Matsumoto, Chizuko Hashimoto, Sachiya Takemura, Etsuko Yamazaki, Katsumichi Fujimaki, Rika Sakai, Shigeki Motomura, Yoshiaki Ishigatsubo. Beta-2 microglobulin is a strong prognostic factor in patients with DLBCL receiving R-CHOP therapy. Leukemia Research 2015;39:1187
- Riwaj Bhagat, Asna Shahab, Yukesh Karki, Samip Budhathoki, Mikki Sapkota. Intravascular Lymphoma-Associated Stroke: A Systematic Review of Case Studies. 2023
- Mohleen Kang, Nitasha Bhatia, Adrienne Sauder, Mirela Feurdean. Angioimmunoblastic T Cell Lymphoma Mimicking Chronic Urticaria. Case Reports in Medicine 2016;2016:1
- Gaetano Romano. Tumor markers currently utilized in cancer care. MATER METHODS 2015;5
- Sung Whan Cha, In Sik Shin, Deok Gie Kim, Sung Hoon Kim, Jun Young Lee, Jae Seok Kim, Jae Won Yang, Byoung-Geun Han, Seung Ok Choi. Effectiveness of serum beta-2 microglobulin as a tool for evaluating donor kidney status for transplantation. Sci Rep 2020;10
- Taichi Omachi, Naho Atsumi, Takashi Yamazoe, Sohsaku Yamanouchi, Ryosuke Matsuno, Tomoki Kitawaki, Kazunari Kaneko. Differential Diagnosis of Histiocytic Necrotizing Lymphadenitis and Malignant Lymphoma with Simple Clinical Findings. Children 2022;9:290
- Sujit Kumar Verma, Anja Karin Albrecht, Verena Siebecke, Gerd Klöck, Tatiana A. Kolesnikova, Sebastian Springer, Christina Chan. Comparative validation of a microcapsule-based immunoassay for the detection of proteins and nucleic acids. PLoS ONE 2018;13:e0201009
- Xin Zhang, Yang Han, Yu Nie, Yujie Jiang, Xiaohui Sui, Xueling Ge, Fang Liu, Ya Zhang, Xin Wang. PAX5 aberrant expression incorporated in MIPI-SP risk scoring system exhibits additive value in mantle cell lymphoma. J Mol Med 2023;101:595
- Abdulkerim Yıldız, Murat Albayrak, Çiğdem Pala, Hacer B Afacan Öztürk, Senem Maral, Osman Şahin, Pınar Cömert. The incidence and risk factors of thrombosis and the need for thromboprophylaxis in lymphoma and leukemia patients: A 9-year single-center experience. J Oncol Pharm Pract 2020;26:386
- Gilles Grangé, Marie Clémence Leguy, Vassilis Tsatsaris, Jean Guibourdenche. Biomarkers in Kidney Disease. 2020.
- Georgia Kaiafa, Mattheos Bobos, Christos Savopoulos, Theocharis Koutsokostas, Kostas Kouskouras, Anna Kalogera-Fountzila, Thomas Zaraboukas, Ioannis Kostopoulos, Vassilis Perifanis, Stavros Hadjimiltiades. RETRACTED: An Uncommon Case of Secondary Cardiac Lymphoma Manifested through Pre-Syncope, Syncope Episodes and Atrial Flutter. JCT 2016;07:986
- Ji‐Wei Li, Ya‐Jun Li, Mei‐Zuo Zhong, Xian‐Ling Liu, Jin Li, Kun‐Lun Li, Xi‐Yu Liu, Fang Zhou, Zhou OuYang, Zhong‐Yi Sun, Li‐Jun Huang, Jun‐Qiao He, Hui Zhou, Ping‐Yong Yi. Efficacy and tolerance of GELOXD/P‐GEMOXD in newly diagnosed nasal‐type extranodal NK/T‐cell lymphoma: A multicenter retrospective study. European J of Haematology 2018;100:247
- Bayazid Ghaderi, Sabrieh Amini, Farzad Maroofi, Chiya Jalali, Mitra Javanmardi, Daem Roshani, Mohammad Abdi. Adenosine Deaminase Activity in Chronic Lymphocytic Leukemia and Healthy Subjects. Iran J Cancer Prev 2016;9
- Christos P. Argyropoulos, Shan Shan Chen, Yue-Harn Ng, Maria-Eleni Roumelioti, Kamran Shaffi, Pooja P. Singh, Antonios H. Tzamaloukas. Rediscovering Beta-2 Microglobulin As a Biomarker across the Spectrum of Kidney Diseases. Front. Med. 2017;4
- Nadia Sarween, Mark T. Drayson, James Hodson, Ellen M. Knox, Timothy Plant, Clara J. Day, Graham W. Lipkin. Humoral immunity in late‐onset Pre‐eclampsia and linkage with angiogenic and inflammatory markers. American J Rep Immunol 2018;80
- Cem Mirili, Semra Paydas, Tuba Korkmaz Kapukaya, Ali Yılmaz. Systemic immune-inflammation index predicting survival outcome in patients with classical Hodgkin lymphoma. Biomarkers in Medicine 2019;13:1565
- Michael J. Boyer, Satoru Eguchi. Novel role for cardiac myocyte-derived β-2 microglobulin in mediating cardiac fibrosis. 2018;132:2117
- Ling Li, Mei Dong, Xiao-Guang Wang. The Implication and Significance of Beta 2 Microglobulin. 2016;129:448
- Tiantong Jiang, Xiurong Ding, Weixing Lu. The Prognostic Significance of Beta2 Microglobulin in Patients with Hemophagocytic Lymphohistiocytosis. Disease Markers 2016;2016:1
- Samuel Lara-Reyna, James A. Poulter, Elton J.R. Vasconcelos, Mark Kacar, Michael F. McDermott, Reuben Tooze, Rainer Doffinger, Sinisa Savic. Identification of Critical Transcriptomic Signaling Pathways in Patients with H Syndrome and Rosai-Dorfman Disease. J Clin Immunol 2021;41:441
- Alexandre Bertucci, Céline Boucard, Vincent Harlay, Romain Appay, Gregorio Petrirena, Maryline Barrié, Olivier Chinot, Emeline Tabouret. Prognostic value of Beta 2-Microglobulinin in cerebrospinal fluid in primary central nervous system lymphoma.. Journal of the Neurological Sciences 2024;457:122847
- Sora Kang, Hyungwoo Cho, Shin Kim, Kyoungmin Lee, Eun Hee Kang, Jung Sun Park, Yoon Sei Lee, Chan-Sik Park, Heounjeong Go, Jooryung Huh, Jin Sook Ryu, Sang-Wook Lee, Seok Jin Kim, Won Seog Kim, Sang Eun Yoon, Young Hyeh Ko, Cheolwon Suh. A New Prognostic Index for Extranodal Natural Killer/T-Cell Lymphoma:Incorporation of Serum β-2 Microglobulin to PINK. Cancer Res Treat 2023;55:314
- Andrew Li, Limei Poon, Kay-Leong Khoo, Ju-Ee Seet, Arvind Kumar Sinha, Pyng Lee. A Man With Pleural Effusion and Ascites. Chest 2015;147:e208
- Ning-Chun Chen, Hung Chang, Hsiao-Wen Kao, Che-Wei Ou, Ming-Chung Kuo, Po-Nan Wang, Tung-Liang Lin, Jin-Hou Wu, Yu-Shin Hung, Yi-Jiun Su, Yuen-Chin Ong, Hsuan-Jen Shih. Beta2-microglobulin is a valuable marker and identifies a poor-prognosis subgroup among intermediate-risk patients with diffuse large B cell lymphoma. Clin Exp Med 2023;23:3759
- Jae‐Hyeon Im, Su‐Min Park, Ju‐Hyun An, Tea‐Hee Kim, Hyung‐Kyu Chae, Ye‐In Oh, Kyoung‐Won Seo, Hwa‐Young Youn. Evaluation of serum interleukin 2 receptor and beta‐2‐microglobulin as prognostic factors for canine lymphoma: A pilot study. Vet Comparative Oncology 2023;21:184
- Sujit K. Verma, Amanda Amoah, Ulla Schellhaas, Mathias Winterhalter, Sebastian Springer, Tatiana A. Kolesnikova. “To Catch or Not to Catch”: Microcapsule‐Based Sandwich Assay for Detection of Proteins and Nucleic Acids. Adv Funct Materials 2016;26:6015
- Daniel Silva Nogueira, Luís Alberto de Pádua Covas Lage, Hebert Fabrício Culler, Juliana Pereira. Follicular Lymphoma: Refining Prognostic Models and Impact of Pod-24 in Clinical Outcomes. Clinical Lymphoma Myeloma and Leukemia 2022;22:67
- Hunter B. Moore, Ernest E. Moore, Alexander P. Morton, Eduardo Gonzalez, Miguel Fragoso, Michael P. Chapman, Monika Dzieciatkowska, Kirk C. Hansen, Anirban Banerjee, Angela Sauaia, Christopher C. Silliman. Shock-induced systemic hyperfibrinolysis is attenuated by plasma-first resuscitation. 2015;79:897
- Manal Mohamed Makhlouf, Eman Roshdy Radwan, Ola Mohamed Khorshed, Lamees Mohamed Fathi, Manal Mohamed Elmasry. CXC Chemokine Receptor Type 5 Gene Polymorphisms in a Cohort of Egyptian Patients with Diffuse Large B-Cell Lymphoma. Pathobiology 2021;88:211
- Gilles Grangé, Marie Clémence Leguy, Vassilis Tsatsaris, Jean Guibourdenche. Biomarkers in Kidney Disease. 2021.
- Ingrid Ruiz-Ordoñez, Juan-Manuel Piedrahita, Javier-Andrés Arévalo, Andrés Agualimpia, Gabriel J. Tobón. Lymphomagenesis predictors and related pathogenesis. Journal of Translational Autoimmunity 2021;4:100098